Monobodies as tool biologics for accelerating target validation and druggable site discovery is a research paper published in RSC Medicinal Chemistry (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01 CA194864
National Cancer Institute
Grant: R01 CA212608
National Institute of Allergy and Infectious Diseases
Grant: R21 AI158997
American Cancer Society
Grant: PF-18-180-01-TBE
National Institutes of Health
Grant: 7R01CA212608-02
Probing RAS-mediated signaling mechanisms with monobody inhibitors
National Institutes of Health
Grant: 1R01CA194864-01A1
Molecular mechanisms of SHP2 signaling dissected with designer binding proteins
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-INF/6762/2020
MS3: New foundations for micro-services and serverless systems
National Institutes of Health
Grant: 1R21AI158997-01
Accurate prediction of neutralization capacity from deep mining of SARS-CoV-2 serology
Fields of Study
Keywords
Sustainable Development Goals